[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY 70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Drugs in Development, 2021 provides in dept...

April 2021 35 pages

Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) - Drugs in Development, 2021

 US$ 3,000.00

Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) - Drugs in Development, 2021 SUMMARY Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14)...

April 2021 30 pages

Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) - Drugs in Development, 2021

 US$ 3,000.00

Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) - Drugs in Development, 2021 SUMMARY Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) - Drugs in...

April 2021 30 pages

Achromatopsia (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Achromatopsia (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Achromatopsia (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Achromatopsia pipeline landscape. The...

April 2021 30 pages

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorder...

April 2021 35 pages

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorder...

April 2021 35 pages

Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021 prov...

April 2021 50 pages

Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Acral Lentiginous Melanoma pip...

April 2021 30 pages

Acute Bronchitis (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Acute Bronchitis (Respiratory) - Drugs in Development, 2021 SUMMARY Acute Bronchitis (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Bronchitis pipeline landscape. The rep...

April 2021 30 pages

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 SUMMARY Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Coronary Syndrome...

April 2021 50 pages

Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021 SUMMARY Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Heart Failure pipeline lan...

April 2021 50 pages

Acute Inflammation (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Acute Inflammation (Immunology) - Drugs in Development, 2021 SUMMARY Acute Inflammation (Immunology) - Drugs in Development, 2021 provides an overview of the Acute Inflammation pipeline landscape. The...

April 2021 45 pages

Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 SUMMARY Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Acute Ischem...

April 2021 125 pages

Acute Liver Failure (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Acute Liver Failure (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Acute Liver Failure (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Acute Liver Failure pipeline...

April 2021 45 pages

Acute Lung Injury (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Acute Lung Injury (Respiratory) - Drugs in Development, 2021 SUMMARY Acute Lung Injury (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Lung Injury pipeline landscape. The...

April 2021 115 pages

Acute Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Acute Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Acute Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Acute Lymphoblastic Lympho...

April 2021 45 pages

Acute Opioid Overdosage (Toxicology) - Drugs in Development, 2021

 US$ 2,000.00

Acute Opioid Overdosage (Toxicology) - Drugs in Development, 2021 SUMMARY Acute Opioid Overdosage (Toxicology) - Drugs in Development, 2021 provides an overview of the Acute Opioid Overdosage pipeline...

April 2021 40 pages

Acute Promyelocytic Leukemia (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Acute Promyelocytic Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY Acute Promyelocytic Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Acute Promyelocytic Leukem...

April 2021 35 pages

Acute Respiratory Failure (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Acute Respiratory Failure (Respiratory) - Drugs in Development, 2021 SUMMARY Acute Respiratory Failure (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Respiratory Failure...

April 2021 30 pages

Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021 SUMMARY Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an...

April 2021 45 pages

Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Acute...

April 2021 35 pages

Addiction (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Addiction (Central Nervous System) - Drugs in Development, 2021 SUMMARY Addiction (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Addiction pipeline landscape. The re...

April 2021 45 pages

Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021 SUMMARY Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021 provides an over...

April 2021 260 pages

Adenocarcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Adenocarcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Adenocarcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Adenocarcinoma pipeline landscape. The report provides...

April 2021 100 pages

Adenoid Cystic Carcinoma (ACC) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Adenoid Cystic Carcinoma (ACC) (Oncology) - Drugs in Development, 2021 SUMMARY Adenoid Cystic Carcinoma (ACC) (Oncology) - Drugs in Development, 2021 provides an overview of the Adenoid Cystic Carcino...

April 2021 60 pages

Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) - Drugs in Development, 2021

 US$ 3,000.00

Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) - Drugs in Development, 2021 SUMMARY Adenosine Monophosphate Activated P...

April 2021 120 pages

Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021

 US$ 3,000.00

Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021 SUMMARY Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021 provides in depth analysis on Adenosine Receptor A1 (ADORA1) targeted pi...

April 2021 45 pages

Adenosine Receptor A2a (ADORA2A) - Drugs in Development, 2021

 US$ 3,000.00

Adenosine Receptor A2a (ADORA2A) - Drugs in Development, 2021 SUMMARY Adenosine Receptor A2a (ADORA2A) - Drugs in Development, 2021 provides in depth analysis on Adenosine Receptor A2a (ADORA2A) targe...

April 2021 90 pages

Adenoviridae Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Adenoviridae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Adenoviridae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Adenoviridae Inf...

April 2021 55 pages

Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) - Drugs in Development, 2021

 US$ 3,000.00

Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) - Drugs in Development, 2021 SUMMARY Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Memb...

April 2021 35 pages

ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2' Phospho ADP Ribosyl Cyclase/2' Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or EC 3.2.2.6 or EC 2.4.99.20) - Drugs in Development, 2021

 US$ 3,000.00

ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2' Phospho ADP Ribosyl Cyclase/2' Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or E...

April 2021 50 pages

ADP Ribosylation Factor 6 (ARF6) - Drugs in Development, 2021

 US$ 3,000.00

ADP Ribosylation Factor 6 (ARF6) - Drugs in Development, 2021 SUMMARY ADP Ribosylation Factor 6 (ARF6) - Drugs in Development, 2021 provides in depth analysis on ADP Ribosylation Factor 6 (ARF6) targe...

April 2021 30 pages

Adrenal Gland Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Adrenal Gland Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Adrenal Gland Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Adrenal Gland Cancer pipeline landscape. T...

April 2021 30 pages

Ageing (Other Diseases) - Drugs in Development, 2021

 US$ 2,000.00

Ageing (Other Diseases) - Drugs in Development, 2021 SUMMARY Ageing (Other Diseases) - Drugs in Development, 2021 provides an overview of the Ageing pipeline landscape. The report provides comprehensi...

April 2021 105 pages

Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the...

April 2021 30 pages

Alcoholic Fatty Liver Disease (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Alcoholic Fatty Liver Disease (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Alcoholic Fatty Liver Disease (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Alcoholi...

April 2021 30 pages

Aldehyde Dehydrogenase Mitochondrial (ALDH Class 2 or ALDH E2 or ALDHI or ALDH2 or EC 1.2.1.3) - Drugs in Development, 2021

 US$ 3,000.00

Aldehyde Dehydrogenase Mitochondrial (ALDH Class 2 or ALDH E2 or ALDHI or ALDH2 or EC 1.2.1.3) - Drugs in Development, 2021 SUMMARY Aldehyde Dehydrogenase Mitochondrial (ALDH Class 2 or ALDH E2 or ALD...

April 2021 35 pages

Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) - Drugs in Development, 2021

 US$ 3,000.00

Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) - Drugs in Development, 2021 SUMMARY Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductas...

April 2021 35 pages

ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,000.00

ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK o...

April 2021 70 pages

Alkaline Phosphatase (ALKP or Phosphomonoesterase or Glycerophosphatase or Alkaline Phosphohydrolase or EC 3.1.3.1) - Drugs in Development, 2021

 US$ 3,000.00

Alkaline Phosphatase (ALKP or Phosphomonoesterase or Glycerophosphatase or Alkaline Phosphohydrolase or EC 3.1.3.1) - Drugs in Development, 2021 SUMMARY Alkaline Phosphatase (ALKP or Phosphomonoestera...

April 2021 35 pages

Allergic Asthma (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Allergic Asthma (Respiratory) - Drugs in Development, 2021 SUMMARY Allergic Asthma (Respiratory) - Drugs in Development, 2021 provides an overview of the Allergic Asthma pipeline landscape. The report...

April 2021 115 pages

Allergic Bronchopulmonary Aspergillosis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Allergic Bronchopulmonary Aspergillosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Allergic Bronchopulmonary Aspergillosis (Infectious Disease) - Drugs in Development, 2021 provides an...

April 2021 35 pages

Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Allergic Rhino...

April 2021 40 pages

Alopecia Areata (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Alopecia Areata (Dermatology) - Drugs in Development, 2021 SUMMARY Alopecia Areata (Dermatology) - Drugs in Development, 2021 provides an overview of the Alopecia Areata pipeline landscape. The report...

April 2021 60 pages

Alpha 1 Adrenergic Receptor (ADRA1) - Drugs in Development, 2021

 US$ 3,000.00

Alpha 1 Adrenergic Receptor (ADRA1) - Drugs in Development, 2021 SUMMARY Alpha 1 Adrenergic Receptor (ADRA1) - Drugs in Development, 2021 provides in depth analysis on Alpha 1 Adrenergic Receptor (ADR...

April 2021 60 pages

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) - Drugs in Development, 2021

 US$ 3,000.00

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) - Drugs in Development, 2021 SUMMARY Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or...

April 2021 60 pages

Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) - Drugs in Development, 2021

 US$ 3,000.00

Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) - Drugs in Development, 2021 SUMMARY Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) - Drugs in Development, 2021 prov...

April 2021 35 pages

Alpha 1D Adrenergic Receptor (Alpha 1A Adrenergic Receptor or Alpha 1D Adrenoreceptor or Alpha Adrenergic Receptor 1a or ADRA1D) - Drugs in Development, 2021

 US$ 3,000.00

Alpha 1D Adrenergic Receptor (Alpha 1A Adrenergic Receptor or Alpha 1D Adrenoreceptor or Alpha Adrenergic Receptor 1a or ADRA1D) - Drugs in Development, 2021 SUMMARY Alpha 1D Adrenergic Receptor (Alph...

April 2021 30 pages

Alpha 2 Adrenergic Receptor (ADRA2) - Drugs in Development, 2021

 US$ 3,000.00

Alpha 2 Adrenergic Receptor (ADRA2) - Drugs in Development, 2021 SUMMARY Alpha 2 Adrenergic Receptor (ADRA2) - Drugs in Development, 2021 provides in depth analysis on Alpha 2 Adrenergic Receptor (ADR...

April 2021 60 pages

Alpha Adrenergic Receptor (ADRA) - Drugs in Development, 2021

 US$ 3,000.00

Alpha Adrenergic Receptor (ADRA) - Drugs in Development, 2021 SUMMARY Alpha Adrenergic Receptor (ADRA) - Drugs in Development, 2021 provides in depth analysis on Alpha Adrenergic Receptor (ADRA) targe...

April 2021 30 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1